Cargando…
Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice
Inhibitors of phosphodiesterase-4 (PDE4) have beneficial effects on memory in preclinical and clinical studies. Development of these drugs has stalled due to dose-limiting side effects of nausea and emesis. While use of subtype-selective inhibitors (i.e., for PDE4A, B, or D) could overcome this issu...
Autores principales: | Zhang, Chong, Xu, Ying, Chowdhary, Anirudh, Fox, David, Gurney, Mark E., Zhang, Han-Ting, Auerbach, Benjamin D., Salvi, Richard J., Yang, Mingxin, Li, Gaowen, O’Donnell, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135860/ https://www.ncbi.nlm.nih.gov/pubmed/30131563 http://dx.doi.org/10.1038/s41386-018-0178-6 |
Ejemplares similares
-
A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway
por: Wang, Yulu, et al.
Publicado: (2020) -
Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor
por: Cui, Su-Ying, et al.
Publicado: (2019) -
The Basic Psychological Needs in the Classroom Scale (BPN-CS)
por: Conesa, Pedro Javier, et al.
Publicado: (2021) -
Development of a novel peptide inhibitor of subtilisin BPN′
por: Ishida, Kohki, et al.
Publicado: (2022) -
Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606
por: Wagner, Steven L., et al.
Publicado: (2017)